Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis. 2015

Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
Division of Cardiology, Hartford Hospital, Hartford, Connecticut, United States of America.

BACKGROUND Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness in people over 65 years old in the United States and has been associated with cardiovascular risk and decreased survival. There is conflicting data, however, regarding the contribution of AMD to the prediction of stroke. OBJECTIVE To determine whether AMD is a risk indicator for incident stroke in a meta-analysis of available prospective and retrospective cohort studies published in the English literature. METHODS We performed a systematic literature search of all studies published in English with Pub Med and other databases from 1966 to August 2014, reporting stroke incidence in patients with macular degeneration. Two investigators independently extracted the data. A random effects model was used to report Odds ratios (OR), with corresponding 95% confidence intervals (CI). Meta-regression using a mixed linear model was used to understand potential heterogeneity amongst studies. RESULTS We identified 9 studies that reported stroke incidence in patients with and without early AMD (N = 1,420,978). No significant association was found between early AMD with incident stroke. Combined, these 9 studies demonstrated random effects (OR, 1.12; CI, 0.86-1.47; I2 = 96%). Meta-regression on baseline covariates of age, sex, and year of publication did not significantly relate to heterogeneity. CONCLUSIONS We found no significant relationship between AMD and incident stroke. Further studies are needed to clarify other causes of decreased survival in patients with AMD.

UI MeSH Term Description Entries
D008268 Macular Degeneration Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms. Maculopathy,Maculopathy, Age-Related,Age-Related Macular Degeneration,Age-Related Maculopathies,Age-Related Maculopathy,Macular Degeneration, Age-Related,Macular Dystrophy,Maculopathies, Age-Related,Age Related Macular Degeneration,Age Related Maculopathies,Age Related Maculopathy,Age-Related Macular Degenerations,Degeneration, Macular,Dystrophy, Macular,Macular Degeneration, Age Related,Macular Degenerations,Macular Dystrophies,Maculopathies,Maculopathy, Age Related
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
June 2017, Ophthalmic epidemiology,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
October 2013, Ophthalmology,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
August 2017, American journal of ophthalmology,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
January 2018, American journal of ophthalmology,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
May 2018, Acta ophthalmologica,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
January 2021, Survey of ophthalmology,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
October 2021, The British journal of ophthalmology,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
December 2010, BMC ophthalmology,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
June 2021, Ophthalmology and therapy,
Antonio B Fernandez, and Gregory A Panza, and Benjamin Cramer, and Saurav Chatterjee, and Ramya Jayaraman, and Wen-Chih Wu
January 2014, PloS one,
Copied contents to your clipboard!